Results 281 to 290 of about 112,374 (313)
Some of the next articles are maybe not open access.
Ventricular arrhythmias in heart failure with reduced ejection fraction
Current Opinion in Cardiology, 2020Purpose of review To provide a framework for approaching ventricular arrhythmias in the setting of cardiomyopathy, outline the latest evidence-based recommendations for catheter ablation and device therapy, and discuss novel treatment strategies.
Aleksandr Voskoboinik, Joshua D. Moss
openaire +3 more sources
Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction
2016Biomarkers are increaingly being used in the management of heart failure not only for the purpose of screening, diagnosis, and risk stratification, but also as a guide to evaluate the response to treatment in the individual patient and as an entry criterion and/or a surrogate marker of efficacy in clinical trials testing novel drugs.
Senni M.+3 more
openaire +2 more sources
The Importance of Heart Rate in Heart Failure and Reduced Ejection Fraction
Journal of Cardiovascular Nursing, 2018Background: Heart failure with reduced ejection fraction (HFrEF) is a progressive, chronic, and burdensome cardiovascular condition. It is associated with limiting symptoms, such as dyspnea and fatigue; a decline in functional capacity; and premature mortality and hospitalization. In heart failure (HF) management, heart rate is
Nancy M. Albert, Marilyn A. Prasun
openaire +3 more sources
Canadian Journal of Cardiology, 2017
Alterations in cardiac energy metabolism contribute to the severity of heart failure. However, the energy metabolic changes that occur in heart failure are complex, and are dependent not only on the severity and type of heart failure present, but also on the coexistence of common comorbidities such as obesity and type 2 diabetes.
Gary D. Lopaschuk, Kirstie A. De Jong
openaire +3 more sources
Alterations in cardiac energy metabolism contribute to the severity of heart failure. However, the energy metabolic changes that occur in heart failure are complex, and are dependent not only on the severity and type of heart failure present, but also on the coexistence of common comorbidities such as obesity and type 2 diabetes.
Gary D. Lopaschuk, Kirstie A. De Jong
openaire +3 more sources
Developments in Heart Failure With Reduced Ejection Fraction
JAMA, 2020Arden R. Barry, Ricky D. Turgeon
openaire +5 more sources
Dapagliflozin in patients with heart failure and reduced ejection fraction [PDF]
Rosa Casella+4 more
openaire +2 more sources
Redefining Heart Failure With a Reduced Ejection Fraction
JAMA, 2019Javed Butler+3 more
openaire +3 more sources
Obesity in Heart Failure with Reduced Ejection Fraction
Heart Failure Clinics, 2023Matthew B. Amdahl+2 more
openaire +1 more source